A detailed history of Counterpoint Mutual Funds LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Counterpoint Mutual Funds LLC holds 4,814 shares of PRCT stock, worth $299,671. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,814
Holding current value
$299,671
% of portfolio
0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$67.27 - $99.45 $323,837 - $478,752
4,814 New
4,814 $387,000
Q2 2024

Aug 13, 2024

BUY
$45.73 - $69.19 $155,985 - $236,007
3,411 New
3,411 $208,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $2.78B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Counterpoint Mutual Funds LLC Portfolio

Follow Counterpoint Mutual Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Counterpoint Mutual Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Counterpoint Mutual Funds LLC with notifications on news.